Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Chaney

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Biochemical Pharmacology|January 15, 1984
Reversibility of protein synthesis inhibition by quassinoid antineoplastic agents in a rabbit reticulocyte systemW Willingham, R T Considine, S G Chaney, et al.
Journal of Pharmaceutical Sciences|June 1, 1983
Antitumor agents LIX: effects of quassinoids on protein synthesis of a number of murine tumors and normal cellsI H Hall, Y F Liou, K H Lee, et al.
Carcinogenesis|December 1, 1996
Increased gene specific repair of cisplatin induced interstrand crosslinks in cisplatin resistant cell lines, and studies on carrier ligand specificityL N Petersen, E L Mamenta, T Stevnsner, et al.
Journal of Pharmaceutical Sciences|February 1, 1982
Antitumor agents XLVII: The effects of bisbrusatolyl malonate on P-388 lymphocytic leukemia cell metabolismI H Hall, Y F Liou, K H Lee, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Comparisons of tetrachloro(d,l-trans)1,2-diaminocyclohexane-platinum(IV) biotransformations in the plasma of Fischer 344 rats at therapeutic and toxic dosesP F Carfagna, A Poma, S D Wyrick, et al.
Nucleic Acids Research|January 25, 1991
Sequence effect on incision by (A)BC excinuclease of 4NQO adducts and UV photoproductsD C Thomas, I Husain, S G Chaney, et al.
Cancer Research|October 15, 1990
Role of carrier ligand in platinum resistance in L1210 cellsG R Gibbons, J D Page, S K Mauldin, et al.
Journal of Pharmaceutical Sciences|April 1, 1982
Antitumor agents XLVIII: Structure-activity relationships of quassinoids as in vitro protein synthesis inhibitors of P-388 lymphocytic leukemia tumor cell metabolismY F Liou, I H Hall, M Okano, et al.
Pharmaceutical Research|December 1, 1987
Effect of helenalin and bis(helenalinyl)malonate on nucleic acid and protein synthesis in human KB carcinoma cellsI H Hall, A A Grippo, K H Lee, et al.
Biochemical Pharmacology|November 15, 1989
In vitro inhibition of mouse hepatic mixed-function oxidase enzymes by helenalin and alantolactoneD E Chapman, D J Holbrook, S G Chaney, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Biochemical Pharmacology|January 15, 1984
Reversibility of protein synthesis inhibition by quassinoid antineoplastic agents in a rabbit reticulocyte systemW Willingham, R T Considine, S G Chaney, et al.
Journal of Pharmaceutical Sciences|June 1, 1983
Antitumor agents LIX: effects of quassinoids on protein synthesis of a number of murine tumors and normal cellsI H Hall, Y F Liou, K H Lee, et al.
Carcinogenesis|December 1, 1996
Increased gene specific repair of cisplatin induced interstrand crosslinks in cisplatin resistant cell lines, and studies on carrier ligand specificityL N Petersen, E L Mamenta, T Stevnsner, et al.
Journal of Pharmaceutical Sciences|February 1, 1982
Antitumor agents XLVII: The effects of bisbrusatolyl malonate on P-388 lymphocytic leukemia cell metabolismI H Hall, Y F Liou, K H Lee, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Comparisons of tetrachloro(d,l-trans)1,2-diaminocyclohexane-platinum(IV) biotransformations in the plasma of Fischer 344 rats at therapeutic and toxic dosesP F Carfagna, A Poma, S D Wyrick, et al.
Nucleic Acids Research|January 25, 1991
Sequence effect on incision by (A)BC excinuclease of 4NQO adducts and UV photoproductsD C Thomas, I Husain, S G Chaney, et al.
Cancer Research|October 15, 1990
Role of carrier ligand in platinum resistance in L1210 cellsG R Gibbons, J D Page, S K Mauldin, et al.
Journal of Pharmaceutical Sciences|April 1, 1982
Antitumor agents XLVIII: Structure-activity relationships of quassinoids as in vitro protein synthesis inhibitors of P-388 lymphocytic leukemia tumor cell metabolismY F Liou, I H Hall, M Okano, et al.
Pharmaceutical Research|December 1, 1987
Effect of helenalin and bis(helenalinyl)malonate on nucleic acid and protein synthesis in human KB carcinoma cellsI H Hall, A A Grippo, K H Lee, et al.
Biochemical Pharmacology|November 15, 1989
In vitro inhibition of mouse hepatic mixed-function oxidase enzymes by helenalin and alantolactoneD E Chapman, D J Holbrook, S G Chaney, et al.
Pageof 9